Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > SvA is about to get run over...as predicted
View:
Post by Metalsguy1 on Jun 13, 2022 2:55pm

SvA is about to get run over...as predicted

https://scitechdaily.com/harvard-scientists-have-developed-a-revolutionary-new-treatment-for-diabetes/
Comment by Mercuryfilling1 on Jun 13, 2022 3:51pm
Metals: Though interesting, this animal study (small primate) is a long long way from running anyone over. Some limitations: We note limitations of the present study. Because of logistical, ethical, and cost considerations, NHP allogeneic islet transplantation studies comprise a small number of subjects, limiting statistically comparisons, and the results may not be representative of a larger ...more  
Comment by MustangSalley on Jun 13, 2022 3:58pm
I agree it is far from a threat . They will still need a device. I think at the end of the day that will be the only saving grace .... unless they can show immunotherapy conformal coating works ...which is most likely years away...just my opinion. MS
Comment by Metalsguy1 on Jun 13, 2022 4:27pm
Merc, regardless, Spill's plodding pace and tunnel vision will be the death of this stock. Nevermind the fact that the recent deal with Evotec more than likely will attract a buyer and at these prices we might be lucky to see 1.50 - and most of us who are legacy holders would vote to sell it cheap rather than stick around for the o going shi# show.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities